We fund research with the promise of transforming and saving lives, and partner with our grantees to support translational and clinical studies that address one or more of the following topics:
-
Quantitative or qualitative approaches to understanding the use of metabolic therapies in serious mental illness.
-
Mechanisms of action and predictive biomarkers in using metabolic therapies for serious mental illness.
-
Clinical research investigating the fundamental link between metabolic function and psychiatric illness.
-
Building metabolic approaches into clinical practice, with an emphasis on embedding research into care.
In addition to funding research, we also invest in building capacity across research and clinical fields. Current efforts include creating continuing medical education for medical professionals, supporting funded investigators’ communication capacities, and convening researchers to create consensus treatment guidelines focused on ketogenic therapies.
More than a dozen clinical trials of ketogenic therapy for serious mental illness are now completed or underway for conditions that include major depression, schizophrenia spectrum disorder, bipolar disorder, and anorexia.
Additional trials not listed here are in process for many other brain-based disorders, including anxiety, Alzheimer’s disease, ADHD, autism, post-traumatic stress disorder, and alcohol use disorder.
Highlighted grants
We invest in mechanistic clinical trials and innovative science focused on adapting evidence-based metabolic interventions to bipolar disorder, schizophrenia spectrum disorders, major depression and anorexia nervosa.
METABOLIC PSYCHIATRY RETREATS
Baszucki Group’s annual Metabolic Psychiatry retreats convene researchers, clinicians, entrepreneurs, funders, and those with lived experience in metabolic psychiatry. Now in its third year, the collaborative, discussion-based sessions focus on brainstorming what it will take to change clinical practice and make metabolic therapies, particularly therapeutic carbohydrate restriction, mainstream care for mental illnesses.
2022 RETREAT WELCOME REMARKS
Hear David Baszucki and Jan Ellison Baszucki share their family’s story at the first Metabolic Psychiatry Roadmap Retreat.
Ecosystem Building
We believe that delivering metabolic interventions requires more than high quality research. We support the development of a pioneering community of entrepreneurs, early-stage companies, investors, scientists, physicians, dieticians, scientists, patients, advocates, science influencers, writers and funders.
Early Stage Mental Health Ventures
